UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma

Clinical and experimental immunology, 2019-07, Vol.197 (1), p.74-82

2019

Volltextzugriff (PDF)

Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins

Photochemical & photobiological sciences, 2018, Vol.17 (5), p.539-551

2018

Volltextzugriff (PDF)

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer

British journal of cancer, 2012-08, Vol.107 (4), p.667-674

2012

Volltextzugriff (PDF)

Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies

British journal of cancer, 2002-11, Vol.87 (11), p.1281-1286

2002

Volltextzugriff (PDF)

Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses

Gene therapy, 2004-01, Vol.11 (2), p.152-160

2004

Volltextzugriff (PDF)

HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR

Oncogene, 2016-08, Vol.35 (32), p.4244-4255

2016

Volltextzugriff (PDF)

Clinical significance of disseminated tumour cells in non-small cell lung cancer

British journal of cancer, 2013-09, Vol.109 (5), p.1264-1270

2013

Volltextzugriff (PDF)

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas

British journal of cancer, 1996-04, Vol.73 (8), p.909-916

1996

Volltextzugriff (PDF)

Interferon-γ suppresses S100A4 transcription independently of apoptosis or cell cycle arrest

British journal of cancer, 2003-06, Vol.88 (12), p.1995-2001

2003

Volltextzugriff (PDF)

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Breast cancer targets and therapy, 2017-01, Vol.9, p.185-198

2017

Volltextzugriff (PDF)

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

British journal of cancer, 2000-09, Vol.83 (6), p.743-749

2000

Volltextzugriff (PDF)

High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases

Clinical cancer research, 1997-09, Vol.3 (9), p.1623-1628

1997

Volltextzugriff (PDF)

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

Annals of oncology, 2019-05, Vol.30, p.iii11-iii11

2019

Volltextzugriff (PDF)

32PMicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

23PDesign of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

S100A4 involvement in metastasis : Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme

Cancer research (Chicago, Ill.), 1999-09, Vol.59 (18), p.4702-4708

1999

Volltextzugriff (PDF)

Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients

Annals of oncology, 2019-05, Vol.30, p.iii8-iii8

2019

Volltextzugriff (PDF)

Levels of Cyclin D1 and D3 in Malignant Melanoma: Deregulated Cyclin D3 Expression Is Associated with Poor Clinical Outcome in Superficial Melanoma

Clinical cancer research, 2000-09, Vol.6 (9), p.3614-3620

2000

Volltextzugriff (PDF)

MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene Status

JNCI : Journal of the National Cancer Institute, 1994-09, Vol.86 (17), p.1297-1302

1994

Volltextzugriff (PDF)

Microarray analysis of phosphatase gene expression in human melanoma

British journal of dermatology (1951), 2005-05, Vol.152 (5), p.925-930

2005

Volltextzugriff (PDF)

Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants

International journal of nanomedicine, 2024-01, Vol.19, p.3009-3029

2024

Volltextzugriff (PDF)

Differential expression patterns of S100a2, S100a4 and S100a6 during progression of human malignant melanoma

International journal of cancer, 1997-08, Vol.74 (4), p.464-469

1997

Volltextzugriff (PDF)

Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme

Cancer research (Chicago, Ill.), 1996-12, Vol.56 (23), p.5490-5498

1996

Volltextzugriff (PDF)

Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy

International journal of nanomedicine, 2019-01, Vol.14, p.6269-6285

2019

Volltextzugriff (PDF)

Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxinsElectronic supplementary information (ESI) available. See DOI: 10.1039/c7pp00358g

2018-05

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(114)

Sprache

Englisch
(114)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma

Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer

Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies

Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses

HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR

Clinical significance of disseminated tumour cells in non-small cell lung cancer

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas

Interferon-γ suppresses S100A4 transcription independently of apoptosis or cell cycle arrest

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

32PMicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

23PDesign of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients

S100A4 involvement in metastasis : Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme

Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients

Levels of Cyclin D1 and D3 in Malignant Melanoma: Deregulated Cyclin D3 Expression Is Associated with Poor Clinical Outcome in Superficial Melanoma

MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene Status

Microarray analysis of phosphatase gene expression in human melanoma

Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants

Differential expression patterns of S100a2, S100a4 and S100a6 during progression of human malignant melanoma

Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme

Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy

Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxinsElectronic supplementary information (ESI) available. See DOI: 10.1039/c7pp00358g

Suchergebnisse filtern